List of Tables
Table 1. Pharmaceutical Regulatory Affairs Market Trends
Table 2. Pharmaceutical Regulatory Affairs Market Drivers & Opportunity
Table 3. Pharmaceutical Regulatory Affairs Market Challenges
Table 4. Pharmaceutical Regulatory Affairs Market Restraints
Table 5. Global Pharmaceutical Regulatory Affairs Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Pharmaceutical Regulatory Affairs Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Pharmaceutical Regulatory Affairs Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Pharmaceutical Regulatory Affairs Product Type
Table 9. Key Companies Time to Begin Mass Production of Pharmaceutical Regulatory Affairs
Table 10. Global Pharmaceutical Regulatory Affairs Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Regulatory Affairs as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Pharmaceutical Regulatory Affairs Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Pharmaceutical Regulatory Affairs Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Pharmaceutical Regulatory Affairs Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Pharmaceutical Regulatory Affairs Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Pharmaceutical Regulatory Affairs Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Pharmaceutical Regulatory Affairs Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Pharmaceutical Regulatory Affairs Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Pharmaceutical Regulatory Affairs Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Pharmaceutical Regulatory Affairs Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Pharmaceutical Regulatory Affairs Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Pharmaceutical Regulatory Affairs Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Pharmaceutical Regulatory Affairs Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Pharmaceutical Regulatory Affairs Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Pharmaceutical Regulatory Affairs Sales Value by Region (2019-2024) & (%)
Table 27. Global Pharmaceutical Regulatory Affairs Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Pharmaceutical Regulatory Affairs Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Pharmaceutical Regulatory Affairs Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Pharmaceutical Regulatory Affairs Sales Value, (2025-2030) & (US$ Million)
Table 31. QuintilesIMS Basic Information List
Table 32. QuintilesIMS Description and Business Overview
Table 33. QuintilesIMS Pharmaceutical Regulatory Affairs Products, Services and Solutions
Table 34. Revenue (US$ Million) in Pharmaceutical Regulatory Affairs Business of QuintilesIMS (2019-2024)
Table 35. QuintilesIMS Recent Developments
Table 36. LabCor Basic Information List
Table 37. LabCor Description and Business Overview
Table 38. LabCor Pharmaceutical Regulatory Affairs Products, Services and Solutions
Table 39. Revenue (US$ Million) in Pharmaceutical Regulatory Affairs Business of LabCor (2019-2024)
Table 40. LabCor Recent Developments
Table 41. PAREXEL Basic Information List
Table 42. PAREXEL Description and Business Overview
Table 43. PAREXEL Pharmaceutical Regulatory Affairs Products, Services and Solutions
Table 44. Revenue (US$ Million) in Pharmaceutical Regulatory Affairs Business of PAREXEL (2019-2024)
Table 45. PAREXEL Recent Developments
Table 46. Pharmaceutical Product Development Basic Information List
Table 47. Pharmaceutical Product Development Description and Business Overview
Table 48. Pharmaceutical Product Development Pharmaceutical Regulatory Affairs Products, Services and Solutions
Table 49. Revenue (US$ Million) in Pharmaceutical Regulatory Affairs Business of Pharmaceutical Product Development (2019-2024)
Table 50. Pharmaceutical Product Development Recent Developments
Table 51. INC RESEARCH HOLDINGS Basic Information List
Table 52. INC RESEARCH HOLDINGS Description and Business Overview
Table 53. INC RESEARCH HOLDINGS Pharmaceutical Regulatory Affairs Products, Services and Solutions
Table 54. Revenue (US$ Million) in Pharmaceutical Regulatory Affairs Business of INC RESEARCH HOLDINGS (2019-2024)
Table 55. INC RESEARCH HOLDINGS Recent Developments
Table 56. PRA Health Sciences Basic Information List
Table 57. PRA Health Sciences Description and Business Overview
Table 58. PRA Health Sciences Pharmaceutical Regulatory Affairs Products, Services and Solutions
Table 59. Revenue (US$ Million) in Pharmaceutical Regulatory Affairs Business of PRA Health Sciences (2019-2024)
Table 60. PRA Health Sciences Recent Developments
Table 61. ICON Basic Information List
Table 62. ICON Description and Business Overview
Table 63. ICON Pharmaceutical Regulatory Affairs Products, Services and Solutions
Table 64. Revenue (US$ Million) in Pharmaceutical Regulatory Affairs Business of ICON (2019-2024)
Table 65. ICON Recent Developments
Table 66. Charles River Basic Information List
Table 67. Charles River Description and Business Overview
Table 68. Charles River Pharmaceutical Regulatory Affairs Products, Services and Solutions
Table 69. Revenue (US$ Million) in Pharmaceutical Regulatory Affairs Business of Charles River (2019-2024)
Table 70. Charles River Recent Developments
Table 71. Advent International Basic Information List
Table 72. Advent International Description and Business Overview
Table 73. Advent International Pharmaceutical Regulatory Affairs Products, Services and Solutions
Table 74. Revenue (US$ Million) in Pharmaceutical Regulatory Affairs Business of Advent International (2019-2024)
Table 75. Advent International Recent Developments
Table 76. WuXi AppTec, Inc. Basic Information List
Table 77. WuXi AppTec, Inc. Description and Business Overview
Table 78. WuXi AppTec, Inc. Pharmaceutical Regulatory Affairs Products, Services and Solutions
Table 79. Revenue (US$ Million) in Pharmaceutical Regulatory Affairs Business of WuXi AppTec, Inc. (2019-2024)
Table 80. WuXi AppTec, Inc. Recent Developments
Table 81. Pharmaron Beijing Co., Ltd. Basic Information List
Table 82. Pharmaron Beijing Co., Ltd. Description and Business Overview
Table 83. Pharmaron Beijing Co., Ltd. Pharmaceutical Regulatory Affairs Products, Services and Solutions
Table 84. Revenue (US$ Million) in Pharmaceutical Regulatory Affairs Business of Pharmaron Beijing Co., Ltd. (2019-2024)
Table 85. Pharmaron Beijing Co., Ltd. Recent Developments
Table 86. Hangzhou Tigermed Consulting Co.,Ltd. Basic Information List
Table 87. Hangzhou Tigermed Consulting Co.,Ltd. Description and Business Overview
Table 88. Hangzhou Tigermed Consulting Co.,Ltd. Pharmaceutical Regulatory Affairs Products, Services and Solutions
Table 89. Revenue (US$ Million) in Pharmaceutical Regulatory Affairs Business of Hangzhou Tigermed Consulting Co.,Ltd. (2019-2024)
Table 90. Hangzhou Tigermed Consulting Co.,Ltd. Recent Developments
Table 91. Asymchem Laboratories (Tianjin) Co.,Ltd. Basic Information List
Table 92. Asymchem Laboratories (Tianjin) Co.,Ltd. Description and Business Overview
Table 93. Asymchem Laboratories (Tianjin) Co.,Ltd. Pharmaceutical Regulatory Affairs Products, Services and Solutions
Table 94. Revenue (US$ Million) in Pharmaceutical Regulatory Affairs Business of Asymchem Laboratories (Tianjin) Co.,Ltd. (2019-2024)
Table 95. Asymchem Laboratories (Tianjin) Co.,Ltd. Recent Developments
Table 96. Accell Clinical Research, LLC. Basic Information List
Table 97. Accell Clinical Research, LLC. Description and Business Overview
Table 98. Accell Clinical Research, LLC. Pharmaceutical Regulatory Affairs Products, Services and Solutions
Table 99. Revenue (US$ Million) in Pharmaceutical Regulatory Affairs Business of Accell Clinical Research, LLC. (2019-2024)
Table 100. Accell Clinical Research, LLC. Recent Developments
Table 101. GenPact Ltd. Basic Information List
Table 102. GenPact Ltd. Description and Business Overview
Table 103. GenPact Ltd. Pharmaceutical Regulatory Affairs Products, Services and Solutions
Table 104. Revenue (US$ Million) in Pharmaceutical Regulatory Affairs Business of GenPact Ltd. (2019-2024)
Table 105. GenPact Ltd. Recent Developments
Table 106. Criterium, Inc. Basic Information List
Table 107. Criterium, Inc. Description and Business Overview
Table 108. Criterium, Inc. Pharmaceutical Regulatory Affairs Products, Services and Solutions
Table 109. Revenue (US$ Million) in Pharmaceutical Regulatory Affairs Business of Criterium, Inc. (2019-2024)
Table 110. Criterium, Inc. Recent Developments
Table 111. Promedica International Basic Information List
Table 112. Promedica International Description and Business Overview
Table 113. Promedica International Pharmaceutical Regulatory Affairs Products, Services and Solutions
Table 114. Revenue (US$ Million) in Pharmaceutical Regulatory Affairs Business of Promedica International (2019-2024)
Table 115. Promedica International Recent Developments
Table 116. Medpace Basic Information List
Table 117. Medpace Description and Business Overview
Table 118. Medpace Pharmaceutical Regulatory Affairs Products, Services and Solutions
Table 119. Revenue (US$ Million) in Pharmaceutical Regulatory Affairs Business of Medpace (2019-2024)
Table 120. Medpace Recent Developments
Table 121. Covance Basic Information List
Table 122. Covance Description and Business Overview
Table 123. Covance Pharmaceutical Regulatory Affairs Products, Services and Solutions
Table 124. Revenue (US$ Million) in Pharmaceutical Regulatory Affairs Business of Covance (2019-2024)
Table 125. Covance Recent Developments
Table 126. Freyr Basic Information List
Table 127. Freyr Description and Business Overview
Table 128. Freyr Pharmaceutical Regulatory Affairs Products, Services and Solutions
Table 129. Revenue (US$ Million) in Pharmaceutical Regulatory Affairs Business of Freyr (2019-2024)
Table 130. Freyr Recent Developments
Table 131. Key Raw Materials Lists
Table 132. Raw Materials Key Suppliers Lists
Table 133. Pharmaceutical Regulatory Affairs Downstream Customers
Table 134. Pharmaceutical Regulatory Affairs Distributors List
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
Table 138. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Pharmaceutical Regulatory Affairs Product Picture
Figure 2. Global Pharmaceutical Regulatory Affairs Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Pharmaceutical Regulatory Affairs Sales Value (2019-2030) & (US$ Million)
Figure 4. Pharmaceutical Regulatory Affairs Report Years Considered
Figure 5. Global Pharmaceutical Regulatory Affairs Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Pharmaceutical Regulatory Affairs Revenue in 2023
Figure 7. Pharmaceutical Regulatory Affairs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Regulatory Consulting Picture
Figure 9. Legal Representation Picture
Figure 10. Regulatory Writing & Publishing Picture
Figure 11. Product Registration & Clinical Trial Application Picture
Figure 12. Other Services Picture
Figure 13. Global Pharmaceutical Regulatory Affairs Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 14. Global Pharmaceutical Regulatory Affairs Sales Value Market Share by Type, 2023 & 2030
Figure 15. Product Picture of In-house
Figure 16. Product Picture of Outsourcing
Figure 17. Global Pharmaceutical Regulatory Affairs Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 18. Global Pharmaceutical Regulatory Affairs Sales Value Market Share by Application, 2023 & 2030
Figure 19. North America Pharmaceutical Regulatory Affairs Sales Value (2019-2030) & (US$ Million)
Figure 20. North America Pharmaceutical Regulatory Affairs Sales Value by Country (%), 2023 VS 2030
Figure 21. Europe Pharmaceutical Regulatory Affairs Sales Value (2019-2030) & (US$ Million)
Figure 22. Europe Pharmaceutical Regulatory Affairs Sales Value by Country (%), 2023 VS 2030
Figure 23. Asia Pacific Pharmaceutical Regulatory Affairs Sales Value (2019-2030) & (US$ Million)
Figure 24. Asia Pacific Pharmaceutical Regulatory Affairs Sales Value by Country (%), 2023 VS 2030
Figure 25. South America Pharmaceutical Regulatory Affairs Sales Value (2019-2030) & (US$ Million)
Figure 26. South America Pharmaceutical Regulatory Affairs Sales Value by Country (%), 2023 VS 2030
Figure 27. Middle East & Africa Pharmaceutical Regulatory Affairs Sales Value (2019-2030) & (US$ Million)
Figure 28. Middle East & Africa Pharmaceutical Regulatory Affairs Sales Value by Country (%), 2023 VS 2030
Figure 29. Key Countries/Regions Pharmaceutical Regulatory Affairs Sales Value (%), (2019-2030)
Figure 30. United States Pharmaceutical Regulatory Affairs Sales Value, (2019-2030) & (US$ Million)
Figure 31. United States Pharmaceutical Regulatory Affairs Sales Value by Type (%), 2023 VS 2030
Figure 32. United States Pharmaceutical Regulatory Affairs Sales Value by Application (%), 2023 VS 2030
Figure 33. Europe Pharmaceutical Regulatory Affairs Sales Value, (2019-2030) & (US$ Million)
Figure 34. Europe Pharmaceutical Regulatory Affairs Sales Value by Type (%), 2023 VS 2030
Figure 35. Europe Pharmaceutical Regulatory Affairs Sales Value by Application (%), 2023 VS 2030
Figure 36. China Pharmaceutical Regulatory Affairs Sales Value, (2019-2030) & (US$ Million)
Figure 37. China Pharmaceutical Regulatory Affairs Sales Value by Type (%), 2023 VS 2030
Figure 38. China Pharmaceutical Regulatory Affairs Sales Value by Application (%), 2023 VS 2030
Figure 39. Japan Pharmaceutical Regulatory Affairs Sales Value, (2019-2030) & (US$ Million)
Figure 40. Japan Pharmaceutical Regulatory Affairs Sales Value by Type (%), 2023 VS 2030
Figure 41. Japan Pharmaceutical Regulatory Affairs Sales Value by Application (%), 2023 VS 2030
Figure 42. South Korea Pharmaceutical Regulatory Affairs Sales Value, (2019-2030) & (US$ Million)
Figure 43. South Korea Pharmaceutical Regulatory Affairs Sales Value by Type (%), 2023 VS 2030
Figure 44. South Korea Pharmaceutical Regulatory Affairs Sales Value by Application (%), 2023 VS 2030
Figure 45. Southeast Asia Pharmaceutical Regulatory Affairs Sales Value, (2019-2030) & (US$ Million)
Figure 46. Southeast Asia Pharmaceutical Regulatory Affairs Sales Value by Type (%), 2023 VS 2030
Figure 47. Southeast Asia Pharmaceutical Regulatory Affairs Sales Value by Application (%), 2023 VS 2030
Figure 48. India Pharmaceutical Regulatory Affairs Sales Value, (2019-2030) & (US$ Million)
Figure 49. India Pharmaceutical Regulatory Affairs Sales Value by Type (%), 2023 VS 2030
Figure 50. India Pharmaceutical Regulatory Affairs Sales Value by Application (%), 2023 VS 2030
Figure 51. Pharmaceutical Regulatory Affairs Industrial Chain
Figure 52. Pharmaceutical Regulatory Affairs Manufacturing Cost Structure
Figure 53. Channels of Distribution (Direct Sales, and Distribution)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
